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Abstract   
 
Background: Metabolic Syndrome is a significant health problem that is currently on the 
rise.  It is associated with an increased risk of type 2 diabetes, as well as a number of 
other health conditions. In addition to lifestyle modifications and pharmaceuticals, 
supplementation with omega 3-fatty acids has shown promise to help with glycemic 
control. This review looks at the effects of flaxseed supplementation on glycemic control 
in adults with or at risk for metabolic syndrome.  
 
Methods:  An exhaustive search of available medical literature was performed using 
Medline-OVID, CINAHL, and Web of Science. Keywords used included: flaxseed, 
flaxseed oil, pre-diabetes, pre-diabetic state, metabolic syndrome X, and metabolic 
syndrome.  
 
Results:  Thirteen articles were reviewed for relevancy. Two studies were found, both 
were RCTs. One of the studies found that supplementing flax with other lifestyle changes 
decreased participants fasting glucose levels, as well as prevented an increase in 
hemoglobin A1c. While the other study did not show any change to patients fasting 
glucose levels. The overall quality of the studies was moderate to low and further studies 
would need to be done that specifically measure levels of insulin resistance in patients 
and follow up for a longer period of time.  
 
Conclusion:  Flax supplementation cannot be used as a reliable method for glycemic 
control in patients with or at risk for metabolic syndrome at this time, but research does 
appear to lean toward the benefits of supplementation.  
 
Keywords:  flaxseed, flaxseed oil, pre-diabetes, pre-diabetic state, metabolic syndrome 
X, metabolic syndrome 
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The Effects of Flaxseed 
Supplementation on Insulin Resistance in 
Adults With or at Risk for Metabolic 
Syndrome  
BACKGROUND 
Metabolic Syndrome affects more than one in five Americans, according to the 
national health survey.1 The risk of developing metabolic syndrome increases with age 
and more than 40% of people in their sixties and seventies are affected. Individuals with 
metabolic syndrome are at approximately twice the risk of cardiovascular disease 
compared to people without this syndrome.2 Furthermore, the risk of developing type 2 
diabetes increases by almost five fold. Since cardiovascular disease (CVD) and diabetes 
are two of the top ten causes of morbidity and mortality in the United States, this is a 
major health concern.3 
Metabolic syndrome is a cluster of metabolic abnormalities which have been 
defined by the National Cholesterol Education Program’s Adult Treatment Panel III 
report (ATP III).4 These abnormalities that make up metabolic syndrome are defined as; 
waist circumference >102cm in males and >88cm in females, triglycerides >150 mg/dl, 
HDL cholesterol <40mg/dl in males and <50mg/dl in females, blood pressure > 135/85 
mmHg, and fasting glucose >110mg/dl. A patient with three of these five components 
can be diagnosed with metabolic syndrome.  
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Metabolic syndrome is an important focus in medicine today because of its 
reversible nature. Individuals with metabolic syndrome or at risk of developing metabolic 
syndrome, can decrease their risk of more serious health complications through lifestyle 
modifications such as dietary modification and aerobic exercise.2-4 Not everyone with 
metabolic syndrome develops diabetes or CVD.  
Most Americans are currently overweight or obese giving them at least one risk 
factor of metabolic syndrome. When examined by the Framingham cohort,4 a study 
focused on identifying the major cardiovascular disease risk factors, it found the presence 
of metabolic syndrome was majorly predictive of new onset diabetes. A variety of 
medications, lifestyle modifications, and supplements have been examined to understand 
their effect on insulin resistance in patients with and at risk for diabetes. The American 
Heart Association currently recommends regular exercise, weight loss, and a healthy diet 
as important elements in prevention and control of diabetes.5 
More recent research has begun examining the relationship of dietary fats and 
how they can modify insulin sensitivity. One type of fat of particular interest has been 
omega-3 fatty acids which are commonly found in seeds. Among the major seed oils, flax 
contains the most omega-3 fatty acids, specifically a-linoleic acid.6 Inclusion of omega 3-
fatty acids in the diet has been associated with improved insulin sensitivity as well as 
glycemic control.7 One study8 found that daily flaxseed consumption resulted in 
statistically significant improvements in glycemic control of type 2 diabetics. Similarly 
another study9 showed that supplementation of flaxseed gum on type 2 diabetics resulted 
in decreased fasting blood glucose levels. 
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While flax supplementation shows promise in diagnosed diabetics, few studies 
have focused on supplementation as a more preventative measure in at risk patients. 
Prevention is of particular interest as metabolic syndrome is expected to continue to rise 
worldwide; its prevalence parallels that of obesity.2 Perhaps supplementing in patients 
who are on the cusp of diabetes, like those with metabolic syndrome, will benefit from 
the addition of omega-3 fatty acids to their diet with diet and exercise.  
METHODS 
An exhaustive search of the literature was performed using Medline- OVID, 
CINAHL, and Web of Science. Keywords used included: flaxseed, flaxseed oil, 
prediabetes, prediabetic state, metabolic syndrome X, and metabolic syndrome. Studies 
were required to use flaxseed supplementation in patients with metabolic syndrome or 
with at least one risk factor of metabolic syndrome and then measure glucose and/or 
hemoglobin A1c levels pre and post supplementation. Other relevant articles were 
searched for further information. Articles were assessed for quality using the Grading of 
Recommendations, Assessment, Development, and Evaluation (GRADE).10 
RESULTS 
A total of 13 articles were reviewed for relevancy. Two articles11,12  fit inclusion 
criteria, both were randomized controlled trials, in English, and the studies were 
performed on humans. See Table I. One study13 examined flaxseed consumption on 
glycemic control in obese adults, but was excluded because it was not a published article, 
rather an abstract recently presented at a medical conference.  
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Wu et al  
This was a randomized control trial11 that looked at the effects of lifestyle 
counseling, lifestyle counseling with flaxseed supplementation, and lifestyle counseling 
with walnut supplementation in adults with or at risk of metabolic syndrome for 12 
weeks. Participants were recruited through two large universities in Shanghai by 
reviewing clinical records of physical exams from 2008. Participants were included if 
they met three of the following criteria: waist circumference > 90 cm for men and >80 
cm for women, triglycerides >1.7 mmol/L, HDL cholesterol <1.03 mmol/L and for men 
<1.30 mmol/L for women, blood pressure > 130/85 mm Hg, fasting glucose > 5.6 
mmol/L, and LDL >3.4 mmol/L. Exclusion criteria included: history of allergy or high 
consumption of nuts, flaxseed, or sesame seeds (>120g/wk), clinically diagnosed renal, 
liver, heart, pituitary, thyroid, mental disease, or diseases affecting absorption, history of 
CVD, cancer, or mental disorder, use of antidepressants, estrogen, or steroid therapy, and 
preganancy or lactation. Patients who responded to recruitment solicitations were then 
invited to attend a screening visit, where their eligibility was confirmed.11  
The study included a total of 283 participants randomized into one of three 
interventions: 1) lifestyle counseling (n=95), 2) lifestyle counseling with 30g/d flaxseed 
supplementation (n=94), and 3) lifestyle counseling with 30g/d walnut supplementation 
(n=94). The intervention included all participants receiving counseling and written 
materials regarding a low-fat diet, limited consumption or red and processed meat, 
consuming <5g/d of salt, increasing consumption of fruits, vegetables, and fish, smoking 
cessation, and moderate wine consumption. At the beginning of the intervention, all 
participants had a one hour group session with a registered dietitian. Two isocaloric 
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breads were provided for each participant every day, breads were similar except 30g 
flaxseed, 30g of walnut, or neither addition were incorporated into the bread. All breads 
were prepared in a single bakery under the supervision of two registered dietitians. 
Adherence was measured by asking participants to return any unused bread that was then 
weighed. In addition the a-linoleic acid content of the erythrocyte membranes was 
measured as a marker of compliance. There were no significant differences in baseline 
characteristics of patients, 90.5% had at least two components of metabolic syndrome.11 
The primary outcome of the study was the effect of flaxseed and walnut 
supplementation as an adjunct intervention to lifestyle counseling on the management of 
metabolic syndrome. Effects were measured through serum glucose, total cholesterol, 
HDL cholesterol, LDL cholesterol, triglycerides, apolipoprotein A-1, B, and E, 
Hemoglobin A1C, serum insulin, and a-linoleic acid levels in erythrocyte membranes. 
The secondary outcome included effect on central obesity. At baseline a food frequency 
questionnaire, a 3-day food record, a 32-general item questionnaire about education, 
physical activity, lifestyle, health status, and medications was administered. Body weight, 
height, BMI, waist circumference, blood pressure, and overnight fasting blood samples 
were obtained at baseline and again at 12 weeks.11  
The percentage of patients with metabolic syndrome decreased from baseline by 
16.9% in the lifestyle counseling group, 20.2% in the lifestyle and flax group, and 16.0% 
in the lifestyle and walnut group. Patients in the lifestyle and flax group had significant 
reversion of hyperglycemia with an odds ratio (95%CI) of 3.01 (1.10-7.54) compared to 
the lifestyle counseling group. Furthermore, the rate of decrease of central obesity was 
higher in the lifestyle counseling and flax group (19.2%, P=0.008) and the lifestyle 
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counseling plus walnut group (16%, P=0.04) compared to the lifestyle counseling group 
(6.3%).11  
A post hoc analysis of between group differences in diabetes related traits among 
participants showed that serum glucose was lower in the flax group compared to the 
lifestyle only group. The between group mean difference was -0.35 mmol/L (95%, -0.69 
to -0.01, P=0.047). Flaxseed supplementation also prevented a rise in participants 
hemoglobin A1c, with a between group difference of -0.10 (95% CI, -0.20 to 0.00, 
P=0.05).11 
Limitations of the study included a relatively short study length. The level of 
blinding was limited, as flaxseed and walnut breads could be differentiated by 
participants based on their appearance and taste. This study was composed of participants 
of Chinese descent only.   
Cornish et al 
This randomized control trial12 sought to look at the effects of a flaxseed lignan 
complex (a fiber associated flax and other plant-based compounds) on metabolic 
composite score and bone mineral in older adults. Participants were recruited through the 
University of Saskatchewan from the general population of Saskatoon and the 
surrounding population through a newspaper advertisement. Patients were required to be 
at least 50 years old, as this age is when patients are at the greatest risk for developing 
cardiovascular disease due to abnormal blood lipid levels. Patients were excluded from 
the study if they were taking medications to lower cholesterol levels, were smokers, had 
type 1 or 2 diabetes, were diagnosed with inflammatory bowel disease, were taking 
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hormone replacement therapy, had ingested flax oil, flax lignin, or flax fibre within the 
last two months, or were involved in exercise training > three times per week.  
A total of 100 participants were randomized into one of two groups. Fifty 
participants were randomized into the flaxseed lignan group and fifty were assigned to 
the placebo group, both groups also completed a six month walking regimen. The 
intervention was three tablets of flax (543 mg) or placebo which were consumed each day 
during the six month intervention. All subjects also completed the same exercise 
intervention, which consisted of walking between 30-60 minutes per day, 6 days a week 
at 50-65% of their predicted maximal heart rate. Compliance was measured by asking 
patients to return any unused supplements to the researchers at the end of the study. 
Overall the groups were balanced prognostically. A total of 6 females and 8 males were 
defined as having metabolic syndrome, according to the Adult Treatment Panel III 
guidelines.12 
Randomization was computer generated by a research assistant who had no other 
involvement in the study. Subjects were enrolled by one of the principal investigators, 
this research assistant in the study assigned participants to the groups. Participants, those 
administering the intervention and those evaluating the outcomes, were blinded to the 
group assignment. Allocation sequence was randomized. They were divided by gender.12 
Primary outcomes for the study included a composite score of metabolic 
syndrome and bone mineral density. The metabolic composite score was calculated by 
determining the sex-specific Z scores of each of the following variables: glucose, HDL 
cholesterol, triacylglycerol, blood pressure, abdominal fat mass, and inflammatory 
markers. Secondary outcomes were blood lipids, IL-6, TNF-a, blood pressure, and body 
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composition as assessed by dual x-ray absorptiometry (DXA). Overnight fasting blood 
samples were obtained at baseline, 2, 4, and 6 months. Height and mass were measured at 
baseline and 6 months. Body composition was assessed at baseline and after 6 months 
with DXA. Waist circumference was measured at baseline.12  
There were no differences in the metabolic syndrome composite score at baseline 
between the placebo and flax lignan group. At 6 months, the metabolic syndrome 
composite z score increased in the male placebo group to a greater extent than in the male 
flax lignan group. Conversly, there were no differences between women in the placebo 
group and women in the flax lignan group in their composite score at six months. In the 
subsample of participants with metabolic syndrome, the males taking the placebo had a 
greater increase in the composite z score + SD (from 0.80 + 0.34 to 1.61 + 0.39, p = 
0.058) compared to those taking the flax lignan (from 0.44 + 0.27 to 0.78 + 0.30, p = 
0.058).12 
Limitations of this study include a high dropout rate of about 19%. Compliance 
monitoring indicated that that the placebo group ingested 88 + 2% and the flax lignan 
group ingested 91 +1%. The study also included a relatively small cohort. Glucose and or 
A1c levels were not analyzed individually, rather interpreted as a composite score 
containing multiple variables. Of the small percentage of participants meeting the 
metabolic syndrome criteria (14%), only one female was assigned to the flax lignan 
group.12 
14 
 
DISCUSSION 
The seriousness of metabolic syndrome is that it puts people at an increased risk 
of many other health complications such as type 2 diabetes. Diabetes is a highly 
researched area and currently some research with the omega-3 fatty acid supplementation 
in diabetics suggests this type of fatty acid, commonly found in seeds such as flax, can 
actually help with insulin and glycemic control.7 
Additionally flax supplementation has received significant recognition in recent 
research6,9 regarding its role in lowering blood pressure and being helpful in the 
prevention of cardiovascular disease. Flaxseed is also a good source of dietary fiber, 
contains all the essential amino acids, and is an excellent source of vitamins and 
minerals.6 It is a readily available supplement found in oil, pills, powdered supplements, 
enriched grains, and many additional food products.6-9 It is a relatively safe product that 
can be found in most US grocery stores, pharmacies, and other retail locations. 
This systematic review yielded two studies11,12 that evaluated the effect of 
flaxseed supplementation on patient’s insulin resistance with or at risk of metabolic 
syndrome. Only one of the two studies11 was able to show that flax supplementation 
decreased fasting blood glucose levels and prevented an increase in participants HbA1c. 
This inconsistency can be explained by the fact that the second study12 evaluated insulin 
resistance as a component of a multivariable composite score making it difficult to 
quantify and examine the effect of flax on glucose levels individually. The studies were 
evaluated using the GRADE method and results can be seen in Table 1. 
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The major limitations of these studies included blinding, cohort size, dropout 
rates, length of study, baseline characteristics, and evaluation of insulin resistance as a 
single component versus part of a composite score. Blinding in the Wu et al study11 was 
particularly difficult as participants could distinguish the flax, walnut, and non-
supplemented bread based on taste and texture. Furthermore the level of blinding in this 
study was not explained.  
In the Cornish et al study12 the cohort consisted of a small number of participants. 
The study which originally consisted of 100 participants lost 19% to follow-up. 
Adherence was also low in this study. In the Wu et al study11 the intervention lasted only 
12 weeks, significant results could have resulted after this study period. The Cornish et al 
study lasted six months, which was still relatively short. Twelve weeks to six months is 
not a long enough time frame to understand to what extent flax supplementation may 
affect glycemic control. Its effects could plateau, increase, or decrease after this amount 
of time.  
The Cornish et al study12 had only 14% of its patients meeting the definition of 
metabolic syndrome. The majority or patients had one or more risk factors. Whereas in 
the Wu et al study11 the majority of patients had at least two components of metabolic 
syndrome and 63.3% met the criteria for metabolic syndrome. The Wu et al study was 
also made up of only Chinese participants in China. These participants could have very 
different lifestyles and diets compared to the US population.  
The Cornish et al study12 did not evaluate insulin resistance as a primary outcome. 
Participants fasting blood glucose was interpreted as part of a composite z score which 
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was made up of 6 variables. A composite score makes it difficult to evaluate the effects 
of each individual variable. One variable could vary significantly causing the composite 
score to change and thus reflecting different results than the variables alone.  
The two studies regarding flax supplementation yielded two different results. The 
Cornish et al12 found that the metabolic composite z score for the male placebo group 
increased to a greater extent than that of the flax group. There were no differences 
between the women in the placebo and flax group. The study suggested that this may be 
related to the decreased number of estrogen receptors in the post-menopausal 
participants, which decreased the flax metabolites ability to bind. Thus the study 
concluded that flax lignan had no effect on glucose levels. Although it did show decrease 
in the metabolic composite score for males taking the flax supplement. In the Wu et al 
study11 flaxseed supplementation was shown to decrease fasting glucose levels and 
prevent the increase in hemoglobin A1c levels of participants. This study also found that 
flax played a role in decreasing central obesity to a greater extent in patients compared to 
the lifestyle and walnut groups.  
Further studies would need to be done on this topic in order to accurately evaluate 
flax supplementation’s effectiveness in improving glycemic control in patients with or at 
risk for metabolic syndrome. Since there are only two studies that evaluated this topic 
and they were of moderate to low quality, the results are not reliable. However, a very 
recent abstract by Hutchins et al13 in February 2013 found that supplementation of 13g of 
ground flaxseed for 12 weeks decreased glucose levels and increased insulin sensitivity in 
patients who were overweight or obese with pre-diabetes. These results along with the 
higher GRADE rating of the Wu et al study11 suggests that flax supplementation is more 
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likely to help improve insulin resistance. A larger, longer lasting randomized control trial, 
comparing flax supplementation with lifestyle modifications in patients with impaired 
fasting glucose levels or elevated hemoglobin A1c levels to placebo and lifestyle 
modifications alone could yield better results.   
CONCLUSION 
The level of the effects of flaxseed supplementation on insulin resistance in 
patients with or at risk of metabolic syndrome is still unclear. There are very few studies 
that currently examine this specific topic. Of the few existing studies, there are 
inconsistent results. The studies have also been of moderate to low quality making it even 
more difficult to determine the effects of flaxseed. However, based on the studies thus 
far, results do suggest that flax supplementation does improve insulin resistance. Further 
studies are needed to determine the effects and get clearer results on this topic.  
Nonetheless, flaxseed supplementation does hold a lot of promise in improving 
insulin resistance. To what extent it helps and what best way to supplement is still 
evolving as this is a very new area of research. Still this is a relatively safe therapy that 
does have proven benefits in decreasing blood pressure and lowering risk of CVD. Due to 
these benefits, as well as possible benefits in glycemic control, it should be considered in 
patients with or at risk of metabolic syndrome.  
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Table I. Characteristics of Reviewed Studies 
 
a Metabolic syndrome was present in a small percentage of the sample population. Variables were not 
analyzed individually but represented as a composite score.  
b Low compliance rate, small sample size, and large loss to follow up. 
c Lack of allocation concealment 
 
 
 
 
 
Quality Assessment  
 Downgrade Criteria 
Quality 
Study Design Limitations Indirectness Imprecision Inconsistency Publication bias likely 
Fasting Blood Glucose +/- HbA1C      Low 
Cornish 
et al12 RCT Serious
a Not serious  Seriousb Not serious No Low 
Wu et 
al11 RCT Serious
c Not serious Not serious Not serious No Moderate 
